UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Mitsubishi UFJ Trust & Banking Corp

Mitsubishi UFJ Trust & Banking Corp lowered its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 0.6% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,077,146 shares of the healthcare conglomerate’s stock after selling 12,400 shares during the period. Mitsubishi UFJ Trust & Banking Corp owned about 0.21% of UnitedHealth Group worth $340,673,000 as of its most recent SEC filing.

A number of other hedge funds have also added to or reduced their stakes in the stock. Patriot Financial Group Insurance Agency LLC raised its position in UnitedHealth Group by 1,722.9% in the first quarter. Patriot Financial Group Insurance Agency LLC now owns 638 shares of the healthcare conglomerate’s stock valued at $106,000 after buying an additional 603 shares in the last quarter. Thomas J. Herzfeld Advisors Inc. purchased a new position in UnitedHealth Group during the fourth quarter valued at approximately $111,000. Cribstone Capital Management LLC raised its position in UnitedHealth Group by 22.6% in the first quarter. Cribstone Capital Management LLC now owns 678 shares of the healthcare conglomerate’s stock valued at $113,000 after buying an additional 125 shares in the last quarter. Israel Discount Bank of New York GFN purchased a new position in UnitedHealth Group during the fourth quarter valued at approximately $139,000. Finally, Parkside Financial Bank & Trust raised its position in UnitedHealth Group by 1.4% in the first quarter. Parkside Financial Bank & Trust now owns 854 shares of the healthcare conglomerate’s stock valued at $140,000 after buying an additional 12 shares in the last quarter. Hedge funds and other institutional investors own 86.37% of the company’s stock.

Shares of UnitedHealth Group Incorporated (NYSE:UNH) traded down 0.04% during mid-day trading on Wednesday, reaching $194.83. The company had a trading volume of 2,125,671 shares. The firm’s 50-day moving average price is $187.91 and its 200 day moving average price is $173.50. UnitedHealth Group Incorporated has a 52-week low of $132.39 and a 52-week high of $196.04. The company has a market cap of $191.91 billion, a price-to-earnings ratio of 23.41 and a beta of 0.64.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, July 18th. The healthcare conglomerate reported $2.46 earnings per share for the quarter, beating the consensus estimate of $2.38 by $0.08. The company had revenue of $50.05 billion during the quarter, compared to analysts’ expectations of $49.97 billion. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.32%. The business’s quarterly revenue was up 7.7% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.96 earnings per share. Equities analysts expect that UnitedHealth Group Incorporated will post $9.87 EPS for the current year.

COPYRIGHT VIOLATION NOTICE: “[[title]]” was posted by [[site]] and is owned by of [[site]]. If you are reading this article on another website, it was illegally copied and republished in violation of international trademark and copyright laws. The original version of this article can be read at [[permalink]].

Several equities analysts have recently commented on UNH shares. Vetr upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $179.00 price target for the company in a research report on Monday, May 15th. Zacks Investment Research upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $199.00 target price for the company in a research report on Tuesday, May 30th. BidaskClub upgraded shares of UnitedHealth Group from a “buy” rating to a “strong-buy” rating in a research report on Saturday, July 8th. Morgan Stanley increased their target price on shares of UnitedHealth Group from $202.00 to $210.00 and gave the company an “overweight” rating in a research report on Wednesday, June 28th. Finally, Mizuho upped their price target on shares of UnitedHealth Group from $178.00 to $200.00 and gave the company a “buy” rating in a report on Tuesday, April 18th. One research analyst has rated the stock with a hold rating and twenty-four have assigned a buy rating to the stock. The stock currently has a consensus rating of “Buy” and a consensus target price of $200.24.

In related news, Director William C. Ballard, Jr. sold 5,000 shares of the firm’s stock in a transaction that occurred on Thursday, August 3rd. The stock was sold at an average price of $193.98, for a total transaction of $969,900.00. Following the completion of the sale, the director now owns 76,058 shares of the company’s stock, valued at $14,753,730.84. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Gail R. Wilensky sold 5,540 shares of the firm’s stock in a transaction that occurred on Friday, June 2nd. The stock was sold at an average price of $178.74, for a total value of $990,219.60. Following the sale, the director now directly owns 60,516 shares of the company’s stock, valued at approximately $10,816,629.84. The disclosure for this sale can be found here. Insiders have sold 15,540 shares of company stock valued at $2,873,320 in the last ninety days. 0.89% of the stock is currently owned by insiders.

About UnitedHealth Group

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.